In the last trading session, 1.0 million shares of the FibroGen Inc (NASDAQ:FGEN) were traded, and its beta was 0.82. Most recently the company’s share price was $0.27, and it changed around $0.01 or 0.83% from the last close, which brings the market valuation of the company to $26.89M. FGEN currently trades at a discount to its 52-week high of $1.53, offering almost -466.67% off that amount. The share price’s 52-week low was $0.18, which indicates that the current value has risen by an impressive 33.33% since then. We note from FibroGen Inc’s average daily trading volume that its 10-day average is 1.1 million shares, with the 3-month average coming to 974.44K.
FibroGen Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 1 recommended FGEN as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
FibroGen Inc (NASDAQ:FGEN) trade information
Instantly FGEN has showed a green trend with a performance of 0.83% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.3246 on recent trading dayincreased the stock’s daily price by 16.82%. The company’s shares are currently down -49.75% year-to-date, but still down -16.71% over the last five days. On the other hand, FibroGen Inc (NASDAQ:FGEN) is -11.89% down in the 30-day period. We can see from the shorts that 3.71 million shares have been sold at a short interest cover period of 5.22 day(s).
The consensus price target as assigned by Wall Street analysts is $28, which translates to bulls needing to increase their stock price by 99.04% from its current value. Analyst projections state that FGEN is forecast to be at a low of $28 and a high of $28.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 11.75%. FibroGen Inc earnings are expected to increase by -1.04% in 2025, but the outlook is negative -10.06% per year for the next five years.
FGEN Dividends
FibroGen Inc’s next quarterly earnings report is expected to be released on 2025-May-11.
FibroGen Inc (NASDAQ:FGEN)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.72% of FibroGen Inc shares, and 33.02% of them are in the hands of institutional investors. The stock currently has a share float of 33.60%. FibroGen Inc stock is held by 73.0 institutions, with PRIMECAP MANAGEMENT CO/CA/ being the largest institutional investor. By 2024-06-30, it held 13.6785% of the shares, which is about 13.66 million shares worth $12.19 million.
ARMISTICE CAPITAL, LLC, with 8.9508% or 8.94 million shares worth $7.97 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
